0 CHECKOUT

PRODUCT FILTERS

REGION

88
63
63
61
61

COUNTRY

61
3
2
2
2

PRICE

0
45
89
252

PUBLISHED

91
102
167
252

PRODUCT TYPE

252

Leukemia

On average over 40,000 are diagnosed with leukemia each year in the United States. It is also one of the most common cancers in children. Large differences in therapeutic outcomes exist among patient groups such as children and old age sufferers, and according to the form of a disease that has many variants such as Acute (AML) and Chronic (CML) Myelocytic Leukemia, Acute (ALL) and Chronic (CLL) Lymphocytic Leukemia, and Hairy Cell Leukemia (HCL). These variations have led to unmet needs among specific patient groups. The selection of expert and insightful reports in this section enable you explore these market opportunities by providing key industry data such as drug development strategies, international market trends and forecasts and profiles of major players like Novartis, Pfizer and Bristol-Myers Squibb. Show Less Read more

Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019

About Chronic Lymphocytic Leukemia Chronic lymphocytic leukemia is a malignant condition characterized by increased production of lymphocytes. It has been observed that the cancer first affects B-lymphocytes...

Published:  August 2015
Price:  From

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

About Acute Myeloid Leukemia Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor...

Published:  December 2014
Price:  From

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – Pipeline Forecast & Market Forecast in G8 Countries (2011 – 2020)

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential with increasing incidence rate of the disease across the globe The incidence of acute lymphocytic/lymphoblastic...

Published:  December 2013
Price:  From

Treating Refractory Hematological Malignancies – Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Emerging Therapeutics

Targeting unmet needs in the treatment of cancer through innovative drug development strategies have witnessed favourable outcomes recently New targets have been validated in this process where kinases...

Published:  August 2013
Price:  From

CAS Triamcinolone World Consumption Report

This CAS Triamcinolone World Consumption Report provides data on the net consumption of CAS 124-94-7 - Triamcinolone Substance(s) in each of the countries listed. The Substance(s) covered (Triamcinolone...

Published:  February 2016
Price: 

CAS Cytarabine World Consumption Report

This CAS Cytarabine World Consumption Report provides data on the net consumption of CAS 147-94-4 - Cytarabine Substance(s) in each of the countries listed. The Substance(s) covered (Cytarabine ) are...

Published:  February 2016
Price: 

Dasatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

CAS Dexamethasone isonicotinate World Consumption Report

This CAS Dexamethasone isonicotinate World Consumption Report provides data on the net consumption of CAS 2265-64-7 - Dexamethasone isonicotinate Substance(s) in each of the countries listed. The Substance(s)...

Published:  February 2016
Price: 

CAS Dexamethasone World Consumption Report

This CAS Dexamethasone World Consumption Report provides data on the net consumption of CAS 50-02-2 - Dexamethasone Substance(s) in each of the countries listed. The Substance(s) covered (Dexamethasone...

Published:  February 2016
Price: 

CAS Cytarabine hydrochloride World Consumption Report

This CAS Cytarabine hydrochloride World Consumption Report provides data on the net consumption of CAS 69-74-9 - Cytarabine hydrochloride Substance(s) in each of the countries listed. The Substance(s)...

Published:  February 2016
Price: 

CAS Triamcinolone acetonide World Consumption Report

This CAS Triamcinolone acetonide World Consumption Report provides data on the net consumption of CAS 76-25-5 - Triamcinolone acetonide Substance(s) in each of the countries listed. The Substance(s)...

Published:  February 2016
Price: 

CAS Triamcinolone diacetate World Consumption Report

This CAS Triamcinolone diacetate World Consumption Report provides data on the net consumption of CAS 67-78-7 - Triamcinolone diacetate Substance(s) in each of the countries listed. The Substance(s)...

Published:  February 2016
Price: 

CAS Prednisone World Consumption Report

This CAS Prednisone World Consumption Report provides data on the net consumption of CAS 53-03-2 - Prednisone Substance(s) in each of the countries listed. The Substance(s) covered (Prednisone ) are...

Published:  February 2016
Price: 

Clofarabine - Comprehensive patent search

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, these In-depth Searches...

Published:  February 2016
Price: 

T-Cell Leukemia-API Insights

Summary T-Cell Leukemia-API Insights, 2015 report provides T-Cell Leukemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear...

Published:  February 2016
Price:  From

Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights

Summary Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Relapsed/ Refractory Chronic Lymphocytic Leukemia...

Published:  February 2016
Price:  From

Relapsed Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights

Summary Relapsed Chronic Lymphocytic Leukemia (CLL)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Relapsed Chronic Lymphocytic Leukemia (CLL). The main objective...

Published:  February 2016
Price:  From

Clofarabine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Dasatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Refractory Leukemia-Pipeline Insights

Summary Refractory Leukemia- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Refractory Leukemia. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients